Skip to main content
. 2019 Aug 12;2(5):333–341. doi: 10.1021/acsptsci.9b00035

Figure 2.

Figure 2

Peptide SAA-1525 identification. (A) SAA-1525 LC-MS signal normalized to spiked-in ACTH fragment (Mean ± SE; **, p < 0.01 by two-way ANOVA). (B) ROC analysis for SAA-1525 differentiation of Ctox and nCtox patients. (C) SAA-1525 peptide peak LC-MS/MS sequence. (D) CTSB cleavage sites in SAA1. Blue arrows indicate CTSB cleavage sites. * indicates a cleavage site not assigned to CTSB activity.